GlassScriptPhysician profile
David H Song
NPI 1174619100
$15,159.89
in general payments reported to CMS, 2019-2025
51 companies · $1,731 in 2025
The $1,731 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,639 · 2020: $2,377 · 2021: $2,379 · 2022: $2,421 · 2023: $1,949 · 2024: $1,665 · 2025: $1,731.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,339 · Education: $5.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,338.93 |
| Education | $5.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $3,545.17 | 2019-2024 | Xarelto |
| Amgen INC. | $1,156.02 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,080.02 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,015.76 | 2019-2025 | Lifevest |
| Pfizer INC. | $919.88 | 2019-2025 | |
| Amarin Pharma, INC. | $856.05 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $619.52 | 2020-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $599.82 | 2019-2025 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $526.45 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Astellas Pharma US INC | $516.50 | 2019-2022 | |
| Esperion Therapeutics, INC. | $509.21 | 2020-2025 | Nexletol |
| Merck Sharp & Dohme LLC | $448.57 | 2021-2025 | Verquvo, Capvaxive |
| Abiomed | $307.10 | 2024-2025 | Impella |
| Novo Nordisk INC | $278.03 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Boston Scientific Corporation | $261.88 | 2021-2025 | Watchman Flx, Watchman Access System, Bodyguardian |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $241.39 | 2025 | Symplicity G3 |
| Astrazeneca Pharmaceuticals LP | $228.90 | 2019-2024 | Farxiga, Brilinta |
| Bayer Healthcare Pharmaceuticals INC. | $219.79 | 2021-2025 | |
| Edwards Lifesciences Corporation | $206.25 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Alnylam Pharmaceuticals INC. | $203.62 | 2020-2025 | Amvuttra, Onpattro |
| Baxter Healthcare | $174.23 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Shockwave Medical, INC | $128.61 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Sanofi-Aventis U.S. LLC | $111.47 | 2019-2024 | |
| Abbott Laboratories | $99.08 | 2021-2023 | Mitraclip |
| Lundbeck LLC | $89.71 | 2019 | |
| Arbor Pharmaceuticals, INC. | $79.51 | 2019 | |
| Vital Connect, INC | $77.68 | 2024 | Vitalpatch Rtm |
| Cardiva Medical, INC. | $74.72 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Gilead Sciences, INC. | $70.94 | 2019 | |
| Glaxosmithkline, LLC. | $58.58 | 2019-2025 | Trelegy Ellipta |
| Kestra Medical Technology Services, INC. | $51.37 | 2023-2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $47.27 | 2019-2021 | |
| Aegerion Pharmaceuticals, INC. | $32.90 | 2019 | |
| Azurity Pharmaceuticals, INC. | $31.94 | 2023 | Edarbyclor |
| Lantheus Medical Imaging, INC. | $30.42 | 2023 | Definity |
| Bridgebio Pharma, INC. | $27.43 | 2025 | Attruby |
| Inspire Medical Systems, INC. | $26.26 | 2025 | Inspire |
| Ionis Pharmaceuticals, INC. | $24.50 | 2025 | Tryngolza |
| Kiniksa Pharmaceuticals International, Plc | $23.42 | 2024 | Arcalyst |
| Dexcom, INC. | $20.83 | 2024 | Dexcom G6 Transmitter |
| Daiichi Sankyo INC. | $18.47 | 2022 | |
| Cvrx, INC. | $17.32 | 2024 | Barostim Neo System |
| Medtronic Vascular, INC. | $17.24 | 2020 | |
| Convatec INC. | $15.68 | 2022 | |
| Cleerly, INC. | $15.55 | 2024 | Cleerly Ischemia, Cleerly Labs |
| Irhythm Technologies, INC. | $15.09 | 2024 | Zio Xt Patch |
| Hikma Pharmaceuticals USA | $14.13 | 2019 | |
| Impulse Dynamics (USA) INC. | $13.61 | 2023 | Optimizer |
| Bardy Diagnostics, INC. | $12.00 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.